UNSPSC 51285303: Nifurquinazol

This classification denotes an antimicrobial with the molecular formula C16H16N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 44E5RRL600, chemically known as 2,2-((2-(5-nitro-2-furyl)-4-quinazolinyl)imino)diethanol but more generally known as nifurquinazol, which bears US NIH Compound Identifier 21139. European Medicines Agency schedules Nifurquinazol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09276MIG.

UNSPSC 51285303 Nifurquinazol is a Commodity code that nominally designates a specific pharmaceutical active ingredient, but the recent state and local opportunities posted under this code do not reflect procurement of nifurquinazol itself. Instead, the tagged solicitations show state and local health agencies buying other pharmaceutical products and medical devices — specifically antibiotics (doxycycline, ciprofloxacin), opioid antagonists (naloxone), and drug deactivation systems. The code shows little relevant recent activity aligned with its stated scope. Illinois Department of Public Health and Seminole County, Florida have been the issuing bodies named in recent records, representing state health departments and county health jurisdictions purchasing through both piggyback cooperative agreements and direct competitive bidding.

Recent opportunities reflect two distinct procurement pathways. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, through the MMCAP Infuse consortium under Invitation for Bid 26482DPHPREPDB53392, supplying doxycycline and ciprofloxacin over a 12-month initial term with renewal options. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, to procure 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the county community health building in Sanford, response deadline July 26, 2023. Activity is limited to Florida and Illinois in the recent record. The code assignment appears to be a tagging mismatch rather than genuine procurement of nifurquinazol, and business development professionals should treat this code as inactive for targeted pursuit.